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1. Introduction 
Traditionally, Mycobacterium species are divided in those belonging to the Mycobacterium 
tuberculosis complex (MTBC), M. leprae and the nontuberculous or atypical mycobacteria 
(NTM), the latter consisting of either rapid (RGM) or slow growing (SGM) species, 
forming colonies, respectively, within seven days of culture or requiring longer 
incubation time (Runyon, 1959). Among the RGM are the M. chelonae complex, including 
M. chelonae, M. abscessus, M. mucogenicum, M. salmoniphilum, M. bolletii and M. massiliense 
(Brown-Elliot & Wallace, 2002; Whipps et al., 2007) and the M. fortuitum complex, 
including M. fortuitum, M. peregrinum,  M. septicum, M. mageritense, M. houstonense and M. 
boenikei (Adékambi & Drancourt, 2004), containing the NTM commonly encountered in 
human specimens. Clinically important SGM are the M. avium complex (MAC), which 
include M. avium, M. intracellulare, M. colombiense and M. chimaera (Tortoli, 2003; Tortoli et 
al., 2004). 
Until now, 130 Mycobacterium species, with a considerable variability in pathogenicity have 
been described, being isolated from natural water reservoirs and drinking water distribution 
systems in buildings, hospitals, household plumbing, hot tubs, spas, building aerosols, 
boreal forest soils and peats, acidic, brown-waters swamps, potting soils and metal removal 
fluid systems (Tortoli, 2009; Euzéby, 2011, Falkinham, 2009). The lack of evidence for 
person-to-person transmission suggests that the environment is the most likely source of 
NTM infection (Marra & Daley, 2002). 
Unlike the bacterial species that belong to the MTBC, NTM are commonly present in the 
environment and when isolated from human specimens, may either be (i) contaminants 
during preparation of sputum cultures in the laboratory, (ii) colonizing organisms of the 
airways without causing disease or (iii) infectious organisms and causing disease and it is 
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not always easy to distinguish between these situations (Griffith et al., 2007). In the case of 
real infection with NTM, clinical syndromes are either lymphadenitis, pulmonary or 
cutaneous infection or disseminated disease, chronic pulmonary infection being the most 
common (Katoch, 2004; Piersimoni & Scarparo, 2009; Tortoli, 2009). Such NMT infections are 
frequently observed in immune-compromised patients in developed nations but also in 
immune-competent individuals with pre-existing structural pulmonary diseases (Griffith et 
al., 2007; Jeong et al., 2004; Jarzembowski & Young, 2008; Bodle et al., 2008; Glassroth, 2008; 
Sexton & Harrison, 2008; Griffith, 2010). 
The diagnosis of NTM pulmonary disease is often difficult due to the overwhelming 
presence of environmental organisms, to the indolent nature of disease and the diversity of, 
mostly, nonspecific clinical symptoms. Therefore, guidelines and criteria for diagnosis of 
NTM pulmonary disease have been published (American Thoracic Society, 1997; British 
Thoracic Society, 2000) followed by the publication of a recent update of more lenient 
criteria (Griffith et al., 2007). Even so, these recommendations do not seem to be satisfactory 
as most patients with pulmonary disease due to NTM do not match these criteria (Marras et 
al., 2007; van Ingen et al., 2009). Also, in endemic countries for tuberculosis (TB), the 
pulmonary disease form is caused also by infection with organisms of the MTBC, presenting 
similar clinical symptoms. In addition, diagnostic procedures for pulmonary TB are sputum 
smear microscopy for acid-fast bacilli (AFB) and X-ray, not differentiating between 
Mycobacterium to the species level. Nonetheless, several case reports and studies on the 
prevalence of pulmonary disease caused by NTM in North America, Europe and Japan have 
been published during the last years (Good, 1980; Tsukamura et al., 1988; von Reyn et al., 
1993; Falkinham, 2002; Kobashi & Matsushima, 2007; Iseman & Marras, 2008; Billinger et al., 
2009; Thomson, 2010; Kendall et al., 2011).  
The impact, magnitude and regional dimension of NTM infections in countries where TB is 
endemic is hardly known (Gopinath & Singh, 2010), such as the case in Brazil, where most 
cases of infectious NTM have been reported in the southeastern region and, more 
specifically, in São Paulo (Barreto & Campos, 2000; Ueki et al., 2005; Zamarioli et al., 2008; 
Pedro et al., 2008). In the Amazon region, North of Brazil, little epidemiological information 
on this matter is available (da Costa et al., 2009). 
We therefore studied the frequency and diversity of NTM isolates, obtained from 
pulmonary specimens from residents of the Pará State, during a twelve year period. 
2. Material and methods 
2.1 Study setting and patients 
All Mycobacterium isolates evaluated were obtained from sputum samples (n = 119) and 
bronchial washings (n = 9) from individuals with clinical symptoms of pulmonary TB and 
residents of the State of Pará, North Brazil (Fig. 1). The study included samples of patients 
from whom NTM was isolated from at least once, and this between January 1999 and 
December 2010, at the Evandro Chagas Institute, a reference center for the diagnosis of 
infections with Mycobacterium. Patient records were reviewed to assess the frequency of 
isolation and clinical relevance of the presence of NTM and the diagnosis for NTM lung 
infection was based on the diagnostic criteria published by the American Thoracic Society 
(Griffith et al., 2007) (Table 1). 
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Fig. 1. Geographic localization of the Pará State, Amazon Region of Brazil. 
 
Clinical and radiographic analysis 
- Pulmonary symptoms that include nodular or cavitary opacities on chest radiograph; 
multifocal bronchiectasis with multiple small nodules on a high resolution computed 
tomography (HRCT) scan; lack of abnormalities suggestive for other disease. 
Microbiologic analysis 
- Positive culture from at least two separate expectorated sputum samples, when initial 
sputum samples are AFB negative, consider repeated sputum AFB smears and cultures or 
positive culture results from at least one bronchial wash or lavage 
Histopathologic analysis 
- Transbronchial or other lung biopsy with mycobacterial histopathologic features 
(granulomatous inflammation or AFB) and positive culture for NTM. 
Table 1. American Thoracic Society diagnostic criteria on NTM pulmonary disease (Griffith 
ei al., 2007). 
2.2 Mycobacterium cultures and isolates 
Pulmonary specimens were decontaminated using the N-acetyl-L-cysteine-sodium 
hydroxide procedure (Webb, 1962; Brasil, 2008), inoculated into Lowenstein-Jensen (LJ) 
medium (Difco, France) and incubated at 35 to 37°C in the absence of light for at least six 
weeks or until colonies appeared. Conventional procedures for distinguishing between 
organisms of the MTBC and of the NTM group included macroscopic analysis of aspect of 
colonies, which MTBC have a rough aspect resemble breadcrumbs or cauliflowers, detection 
of cord factor from MTBC by Ziehl-Neelsen stain, and the growth inhibition test in medium 
containing 0.5 mg/mL para-nitrobenzoic acid, a specific inhibitor of MTBC, all according to 
Kubica (1973). 
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2.3 Sequence analysis and phylogenetic analysis 
Sequencing of part of the 16S ribosomal RNA (16S rRNA) and 65-kilodalton heat shock 
protein (hsp65) genes was performed as described by previous publications (Kim et al., 2005; 
Shin et al., 2006). After verification of PCR products on agarose gel Seakem LE 1% 
(Cambrex, United Kingdom), these were purified using the SNAP TM gel purification kit 
(Invitrogen). The amplified products were direct sequenced by using both forward and 
reverse primers of each system and the BigDye Terminator v3.1 cycle sequencing kits 
(Applied Biosystems, Foster City, CA) and analyzed on an ABI3130 sequencer (Applied 
Biosystems, Tokyo, Japan). 
The 16S rRNA and hsp65 sequences were aligned using the multiple-alignment algorithm of 
the Bioedit software (version 7.0.9; Tom Hall [http://www.mbio.ncsu.edu/BioEdit/ 
bioedit.html]) with the closest relatives retrieved from the GenBank database across of the 
Basic Local Alignment Search Tool (BLAST, URL: http://www.ncbi.nlm.nih.gov/ BLAST/) 
and the Ribosomal Differentiation of Medical Microorganisms RIDOM database (RIDOM, 
URL: http://rdna.ridom.de/). Phylogenetic trees were constructed from the presently-defined 
16S rRNA or hsp65 sequences separately using the neighbor-joining algorithm, including 
sequences of a selection of NTM-type strains, retrieved from GenBank (accession numbers in 
parenthesis next to the species names in Figs.3 and 4). For this, we used the Kimura's 2-
parameter distance correction model and MEGA software (Version 4.0; Tamura et al. 
[http://www.megasoftware.net/]). Bootstrap analysis (1,000 repeats) was applied using the 
Tsukamurela paurometabola (KCTC 9821) sequences as an out-group. The GenBank accession 
numbers for the Mycobacterium sequences determined in this study included the following: 
FJ590454-FJ590472, HM056080- HM056113 for the 16S rRNA, and FJ536235- FJ536253, 
HM056114- HM056147 for the hsp65 gene. 
2.4 Statistical analysis 
Statistical data were derived by using the nonparametric chi-square test and the Fisher exact 
test, where appropriate. P values less than 0.05 was considered significant. Statistical 
analysis was performed with the BioEstat software (version 5.0; Ayres et al. [http: 
www.mamiraua.org.br]).  
3. Results 
3.1 Patients and NTM isolates 
Between 1999 and 2010, Mycobacterium isolates were recovered from respiratory specimens 
of 1,580 patients, that were suspected of having pulmonary TB. Among these, 92% (1,453 
cases) were infected with MTBC; from the rest (8%, 128 patients) we obtained 249 NTM 
isolates. Among the NTM-positive patients studied, 57.5% (n=73) presented at least two 
positive sputum cultures for the same species, or presented at least one bronchial wash 
positive culture and suffered therefore from infections as defined by the criteria of ATS 
(Griffith et al., 2007). The clinical significance of NTM pulmonary isolation among 1999-2010 
is shown in Fig.2.  
The remaining 55 patients could not be confirmed to suffer from NMT infection because (i) 
only a single sputum sample was collected and delivered to the laboratory (47 patients); (ii)  
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Fig. 2. Frequency of NTM isolation from clinical pulmonary specimens of patients from Pará 
State, Brazil, 1999-2010. 
one sample was culture-positive and the others were culture-negative (five cases) or (iii) 
NTM were found in some patients who were also TB-positive (three patients). Distribution 
of species according clinical relevance and years of isolation is show in Tab.2 and Fig.3. 
 
Species 
Clinical relevant Not relevant Total 
Patients Isolates Patients Isolates Patients Isolates 
M. massiliense 20 39 8 8 28 47 
M. simiae complex 14 44 5 5 19 49 
M. intracellulare 11 32 6 6 17 38 
M. avium 10 28 12 12 22 40 
M. bolletii 4 14 0 0 4 14 
M. abscessus 3 8 1 1 4 9 
M. colombiense 3 9 2 2 5 11 
M. kansasii 2 3 0 0 2 3 
M. simiae 2 4 1 1 3 5 
M. fortuitum 1 6 18 18 19 24 
M. scrofulaceum 1 3 0 0 1 3 
M. szulgai 1 2 0 0 1 2 
M. terrae 1 2 0 0 1 2 
M. parascrofulaceum 0 0 1 1 1 1 
M. smegmatis 0 0 1 1 1 1 
Total 73 194 55 55 128 249 
Table 2. Clinical significance of NTM isolated in Pará State, Brazil, 1999-2010. 
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Fig. 3. Frequency of isolation of nontuberculous Mycobacterium species between the 1999-
2003 and 2004-2010 periods in Pará State, Brazil. 
Among the 73 patients with bacteriological ATS criteria for NMT infection, 64.4% (n=47; p = 
0,03) were females and more detailed analysis of their treatment history revealed that 72 had 
previously been unsuccessfully treated for TB, using the first-line multidrug therapy 
scheme; one patient had been diagnosed as suffering from allergic bronchitis and therefore 
submitted to corticosteroid therapy. After confirmation of NTM infection, 70 patients were 
submitted to a daily regimen of clarithromycin (500-1,000 mg) and ethambutol (25 mg/kg) 
for 12 months. No therapy information was available for the patient infected with M. 
fortuitum and for the two cases with M. kansasii. Treatment outcome was not available for all 
cases but patients infected with members of the M. simiae complex did not present clinical 
improvement and at the end of our study period, one had died due to progression of 
disease. 
All of the patients described above presented respiratory complaints consistent with TB 
while additional symptoms were observed (Table 3). Bronchiectasis sequelae occasionally 
associated with hemoptysis in patients infected with M. abscessus (n=1), M. bolletii (n=2), M.  
www.intechopen.com
Pulmonary Nontuberculous Mycobacterial Infections in the  
State of Para, an Endemic Region for Tuberculosis in North of Brazil 
 
43 
Species 
Gender
Clinical characteristics Total 
Male Female
M. massiliense 6 14 
chronic cough (20); sputum (20); chest pain 
(20); hemoptysis (5); dyspnea; loss weight (3) 
20 
M. simiae complex 4 10 
chronic cough (14); sputum (14); chest pain 
(14) weight loss (14); fever (3); hemoptysis (10); 
malaise (14); dyspnea (3); down syndrome (1); 
fatigue (2) 
14 
M. intracellulare 5 6 chronic cough (11); sputum (11); chest pain (3) 11 
M. avium 2 8 
chronic cough (10); sputum (10); chest pain 
(10); HIV (1); gastroesophageal reflux disease 
(1) 
10 
M. bolletii 3 1 
chronic cough (4); hemoptysis (2); decreased 
lung volume (1); fever (1); loss weight (1) 
4 
M. abscessus 1 2 
chronic cough (3); sputum (3); hemoptysis (1); 
dyspnea (1); corticosteroid-
immunosuppressed (1) 
3 
M. colombiense 2 1 chronic cough (3); chest pain (3) 3 
M. kansasii 1 1 chronic cough (2); chest pain (2) 2 
M. simiae 0 2 chronic cough (2); chest pain (2) 2 
M. fortuitum 1 0 chronic cough (1); chest pain (1) 1 
M. scrofulaceum 0 1 chronic cough (1); chest pain (1) 1 
M. szulgai 0 1 chronic cough (1); chest pain (1) 1 
M. terrae 1 0 chronic cough (1); chest pain (1) 1 
Table 3. Clinical characteristics of patients with NTM pulmonary infection from Pará State, 
Brazil, 1999-2010. 
massiliense (n=5) and M. simiae complex (n=10) while chronic cough was observed among 
patients, independent of the infecting Mycobacterium species. The interval between the onset 
of signs and symptoms and a definitive diagnosis of NTM infection was greater than 12 
months, being more pronounced in cases with M. simiae complex isolates, reporting the 
presence of symptoms for at least 24 months. 
3.2 NTM Identification on the genetic level 
Based on 16S rRNA gene analysis, the majority of the NTM species isolated from patients 
could be grouped into three clades, containing sequences from either M. avium, M. chelonae 
or M. simiae complexes (Fig. 4). 
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Fig. 4. Relationships between sequences from the type strains and the NTM isolated 
presently, inferred from partial 16S rRNA gene. Phylogenetic tree was constructed by 
neighbor-joining method and Kimura's 2-parameter distance correction model. The support 
of each branch, as determined from 1000 bootstrap samples, is indicated by the value at each 
node (as a percentage). T. paurometabola KCTC 9821 was used as outgroup. 
Upon sequence analysis of part of the hsp65 gene, we observed a higher genetic diversity 
than that of the 16S rRNA gene; nonetheless, the phylogenetic tree based on hsp65 gene 
sequence analysis had the same global topology as that based on 16S rRNA gene (Fig. 5).  
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Fig. 5. Relationships between sequences from the type strains and the NMT isolated 
presentlty, as inferred from partial hsp65 sequences. Phylogenetic tree was constructed as 
described above. 
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Among the 249 infectious isolates, 200 NMT sequences, derived from 108 patients, had 
already been described elsewhere and characteristic for 14 NMT species, the other 49 
sequences derived from 19 cases were unpublished in public databases and all 
phylogenetically classified into the M. simiae complex. 
4. Discussion 
This study demonstrates that among 1,453 cases that were diagnosed between 1999 and 2010 
as suffering from pulmonary TB, presence of NTM was observed in 128 (8%) of these and 
infection with such species proven to cause disease in 73 cases (5%). It was observed a 
steady increase in the number of NTM isolates during the study period, which was more 
pronounced from 2004 on, when an increase in the demand of culture for AFB at the 
Evandro Chagas Institute was the case. This latter could be due either to the increase of the 
physicians’ sensitivity to occurrence of NTM infections in this region and/or to an increase 
of infection with NMT of the population. 
In this study, significantly more females were infected with NTM, and this is contrary to 
most published data, presenting males as the major risk group for pulmonary NMT disease 
(Marras & Daley, 2002). However, some recent reports also demonstrated a female 
predominance (Freeman et al., 2007; Cassid et al., 2009; Prevot et al., 2010; Wintrop et al., 
2010), in concordance with the recent data of Chan & Iseman (2010), describe a higher 
immune susceptibility of women to NTM pulmonary disease. In addition, when stratifying 
to the NMT species level, it was observed that gender associated infection was even more 
pronounced in the case of M. massiliense (70% females), M. simiae complex (71%) and M. 
avium (66%). Griffith et al. (2003) found a predominance of females (65%) among 154 cases of 
pulmonary disease by RGM, while descriptions of particular forms of pulmonary disease 
caused by MAC in women have been reported (Wallace, 1994; Reich & Johnson, 1995). 
Further studies are needed to elucidate the reasons for female susceptibility. Roughly 40% 
(n=55) of the patients with NTM-positive cultures did not meet the diagnostic criteria for 
NTM pulmonary infection but this does not necessarily mean that the presence of NMT is 
not the cause of disease. Unfortunately, due to lack of follow-up of patients, it cannot 
confirm this presently. There is little known about the pathophysiology of NTM-related 
lung disease what makes it difficult to be certain that colonization is not an indolent or even 
a slowly-progressive infection. Therefore, such cases need to remain under observation and 
seek expert consultation (Griffith et al., 2007). 
Among the cases with confirmation of NMT infection as a cause of disease, mostly, previous 
diagnosis and treatment of TB was observed, none demonstrating improvement following 
treatment. Misdiagnosis of NTM infections as caused by members of the MTBC leads to 
unsuccessful treatment with anti-TB drugs and because clinicians experiment with various 
TB therapies without considering a culture-based test, there is a considerable delay in 
detection of NTM. This is even more a matter of concern in high prevalence countries of TB 
such as Brazil, where mostly, symptomatic patients with sputum smear positive for acid-fast 
bacilli are treated with anti-TB drugs without being testing for NTM-related disease, except 
when co-infected with HIV (Brasil, 2005). 
In Brazil, it was common until 2009, to start second line treatment without performing 
culture test for NTM, when no improvement during the first round of TB treatment was 
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observed. The high level of pulmonary NTM that was misdiagnosed as TB strongly suggests 
the need for a different strategy of TB control in the state of Para.  
In most countries, NTM-related disease, unlike TB, do not need to be reported unless they 
are healthcare-associated infections. Therefore, information on the frequency and diversity 
of NTM infections are usually obtained from laboratory records and surveillance studies 
(Marras et al., 2007; Parrish et al., 2008). To determine the true epidemiological status of 
NTM pulmonary disease, well designed population-based studies are needed. However, the 
financial burden on public health care system in developing countries makes it difficult to 
perform such surveillance studies. Therefore, laboratory procedures such as the 
introduction of both liquid and solid culture systems and use of molecular methods such as 
PCR restriction analysis (PRA) in reference laboratories could be an alternative for more 
knowledge and improvement of diagnose accuracy in those regions.  
Sequence analysis has contributed to the recent description of several new Mycobacterium 
species and more precise identification and taxonomy of members of this genus. Genotypic 
taxonomy is typically based on the detection of highly conserved regions within the genome 
that harbor hypervariable sequences in which species-specific deletions, insertions, or 
replacements of single nucleotides are present in 16S rRNA, hsp65 gene and more recently 
on a fragment of the gene coding for the beta sub-unit of RNA polymerase (rpoB) are also 
contributing to this field, mostly for RGM (da Costa et al., 2009; da Costa et al, 2010). Several 
amplification molecular methods, have been proposed to correct NTM identification, 
including specific DNA probes (AccuProbe: GenProbe, Inc., San Diego, CA, U.S.A) and PRA 
method based on 16S rRNA (Domenech et al., 1994), 16S-23S rRNA internal transcribed 
spacer (ITS) (Roth et al., 1998), hsp65 (Telenti et al., 1993), rpoB (Lee et al., 2000), cold-shock 
protein gene (dnaJ) (Takewaki et al., 1994), DNA repair protein gene (recA) (Blackwood et 
al., 2000) and elongation factor Tu gene (tuf) (Shin et al., 2009), but all have limitations as the 
variety of mycobacteria to be identified (da Costa et al., 2010a, b). 
Based on the 16S rRNA and hsp65 nucleotide sequences, we observed that the most frequent 
NTM isolates from our pulmonary samples were those of the M. avium, M. chelonae and M. 
simiae complexes. The most common NTM were M. massiliense, M. intracellulare, followed by 
Mycobacterium sp. from M. simiae complex. When compared with reports on NMT infections 
observed in other studies reported on Brazilian NTM cases, the species diversity and 
frequency is quite particular to the Para State, suggesting that environmental characteristics 
as temperature, pH and substrate composition may influence the geographical distribution 
of species. Our findings are in concordance with the fact that isolates of the M. simiae 
complex are rarely observed in other regions of Brazil. 
There are few publications describing NTM in the Amazon region or Brazil. Barreto and 
Campos (2000) found 35 patients with NTM and showed that isolates of the M. avium 
complex, M. terrae and M. fortuitum were most common in samples collected between 1994 
and 1999 in North of Brazil. A study that evaluated respiratory samples of non-indigenous 
and indigenous patients from Amazonas State with suspected pulmonary TB identified 19 
patients with NTM infection, but the study did not report the identity of the isolates at the 
species level (Santos et al., 2006). A recent study by da Costa et al. (2009), showed that the M. 
chelonae complex, which includes the M. massiliense species, is the most frequent cause of 
pulmonary infections by RGM in Pará State, Amazon region of Brazil, similar to our 
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observations. Unlikely, in Brazilian southeast, M. kansasii and M. avium represented the most 
frequent type of NTM associated with pulmonary infections between 1991 and 1997 in the 
state of São Paulo (Ueki et al., 2005; Zamarioli et al. 2008; Pedro et al., 2008). 
In contrast to other parts of the world, the species variability found in the present study is 
different. In countries from Latin America like Colombia, MAC, M. chelonae and M. fortuitum 
were the NTM isolated with more frequency (León, 1998), while MAC was most frequently 
isolated from argentinian HIV patients (Di Lonardo, 1995). MAC and M. kansasii were 
predominant in North America, some countries of Europe and South Africa (Griffith et al., 
2007). In Asia, MAC, M. abscessus and M. chelonae were frequently isolated from pulmonary 
samples (Simons et al., 2011). The knowledge on diversity and epidemiology of species 
NTM associated to pulmonary in specific region is important because either: (i) it allows the 
adequate choice of laboratory methods for diagnosis (ii) it allows to recognize the species 
associated to disease; and (iii) it supplies information that will serve to improve the 
organization of health service net to attend these patients. 
Perhaps the most important finding of this study was the identification of M. simiae complex 
members as the predominant cause of pulmonary infections. In fact, roughly 20% (n=16) of 
the pulmonary infections were caused by members of the M. simiae complex and among 
these, 14 belonged to an unidentified taxon (n=14). Currently, this taxonomic group is made 
up of 17 species including M. simiae, M. genavense, M. intermedium, M. interjectum, M. 
lentiflavum, M. triplex, M. heidelbergense, M. kubicae, M. palustre, M. montefiorense, M. 
florentinum, M. sherrisii, M. parmense, M. parascrofulaceum, M. saskatchewanense, M. stomatepiae 
and M. europaeum (Tortoli, 2003, 2006; Tortoli et al., 2010). However, among these species, 
only M. simiae is recognized as a real cause of pulmonary infections, as reported in areas 
such as the Southwest of the United States, Israel and Cuba (Griffith et al., 2007). It is 
estimated that 9 to 21% of the M. simiae isolates from pulmonary specimens have clinical 
relevance (Rynkiewicz et al. 1998). The findings of this study suggest that members of this 
group may have pathogenic potential, but further studies are required to assess the 
characteristics of these isolates, including details on predisposing conditions from patients, 
as well as the drug susceptibility these NTM. 
5. Conclusion 
In conclusion, although our study is not necessarily representative for the whole Amazon 
region, it clearly demonstrates the importance of NTM pulmonary infections in this region. 
Our data also show that a variety of NTM species are involved, and that there is need for 
bacteriologic diagnosis in patients with TB, especially in patients who have failed TB 
treatment. We have shown that the lack of species identification in a significant subset 
(8.0%) of patients with a presumptive diagnosis of TB in a regional reference center can lead 
to misdiagnosis and may be followed by inadequate treatment. 
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